Survival rates among Parkinson's disease patients who carry mutations in the LRRK2 and GBA genes

MoCA for cognitive screening in Parkinson's disease: Beware of floor effect

(2018) Angela Federico et al.   MOVEMENT DISORDERS

Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene

(2018) Avner Thaler et al.   PARKINSONISM & RELATED DISORDERS

Progression in the LRRK2-Associated Parkinson Disease Population

(2018) Rachel Saunders-Pullman et al.   JAMA Neurology

GBA mutations in Parkinson disease: earlier death but similar neuropathological features

(2017) C. H. Adler et al.   EUROPEAN JOURNAL OF NEUROLOGY

Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism

(2017) Rodolfo Savica et al.   JAMA Neurology

Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's

(2016) Ganqiang Liu et al.   ANNALS OF NEUROLOGY

Survival and dementia inGBA-associated Parkinson's disease: The mutation matters

(2016) Roberto Cilia et al.   ANNALS OF NEUROLOGY

The relationship between glucocerebrosidase mutations and Parkinson disease

(2016) Anna Migdalska-Richards et al.   JOURNAL OF NEUROCHEMISTRY

Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in theLRRK2gene

(2015) Anat Mirelman et al.   MOVEMENT DISORDERS

Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease

(2015) Roy N. Alcalay et al.   PARKINSONISM & RELATED DISORDERS

Prognostic factors for early mortality in Parkinson's disease

(2015) Linda P. Oosterveld et al.   PARKINSONISM & RELATED DISORDERS

Olfactory identification inLRRK2G2019S mutation carriers: a relevant marker?

(2015) Rachel Saunders-Pullman et al.   Annals of Clinical and Translational Neurology

Mortality in Parkinson's disease: A systematic review and meta-analysis

(2014) Angus D. Macleod et al.   MOVEMENT DISORDERS

Mortality in Parkinson's disease: A 38-year follow-up study

(2014) Bernadette Pinter et al.   MOVEMENT DISORDERS

A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy Bodies

(2013) Michael A. Nalls et al.   JAMA Neurology

Estimation of Parkinson’s disease survival in Israeli men and women, using health maintenance organization pharmacy data in a unique approach

(2012) O. Chillag-Talmor et al.   JOURNAL OF NEUROLOGY

GBA-associated PD presents with nonmotor characteristics

(2011) K. Brockmann et al.   NEUROLOGY

What predicts mortality in Parkinson disease?: A prospective population-based long-term study

(2010) E. B. Forsaa et al.   NEUROLOGY

Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease

(2009) Juliane Neumann et al.   BRAIN

The LRRK2 G2019S mutation as the cause of Parkinson’s disease in Ashkenazi Jews

(2009) Avner Thaler et al.   JOURNAL OF NEURAL TRANSMISSION

Mortality in Parkinson's disease: A 20-year follow-up study

(2009) Anja Diem-Zangerl et al.   MOVEMENT DISORDERS

LRRK2 and GBA mutations differentially affect the initial presentation of Parkinson disease

(2009) Z. Gan-Or et al.   NEUROGENETICS

Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease

(2009) E. Sidransky et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Spectrum of Parkinsonian Manifestations Associated With Glucocerebrosidase Mutations

(2008) Ozlem Goker-Alpan et al.   ARCHIVES OF NEUROLOGY

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

(2008) Christopher G. Goetz et al.   MOVEMENT DISORDERS

Parkinson disease and risk of mortality: A prospective comorbidity-matched cohort study

(2008) J. A. Driver et al.   NEUROLOGY

Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset

(2008) Z. Gan-Or et al.   NEUROLOGY